133 related articles for article (PubMed ID: 38462823)
21. Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovec.
Anguela XM; High KA
Blood Adv; 2024 Apr; 8(7):1796-1803. PubMed ID: 38592711
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials.
Oladapo AO; Epstein JD; Williams E; Ito D; Gringeri A; Valentino LA
Haemophilia; 2015 Sep; 21(5):e344-58. PubMed ID: 26390060
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study.
Oldenburg J; Tran H; Peyvandi F; Núñez R; Trask P; Chebon S; Mahlangu JN; Lehle M; Jiménez-Yuste V; von Mackensen S
Haemophilia; 2021 May; 27(3):398-407. PubMed ID: 33576546
[TBL] [Abstract][Full Text] [Related]
24. Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B.
Burke T; Shaikh A; Ali TM; Li N; Curtis R; Garcia Diego DA; Recht M; Sannie T; Skinner M; O'Hara J
J Med Econ; 2022; 25(1):386-392. PubMed ID: 35253589
[TBL] [Abstract][Full Text] [Related]
25. Effect of late prophylaxis in hemophilia on joint status: a randomized trial.
Manco-Johnson MJ; Lundin B; Funk S; Peterfy C; Raunig D; Werk M; Kempton CL; Reding MT; Goranov S; Gercheva L; Rusen L; Uscatescu V; Pierdominici M; Engelen S; Pocoski J; Walker D; Hong W
J Thromb Haemost; 2017 Nov; 15(11):2115-2124. PubMed ID: 28836341
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life of moderate and severe haemophilia patients: Results of the haemophilia-specific quality of life index in Korea.
Baek HJ; Park YS; Yoo KY; Cha JH; Kim YJ; Lee KS
PLoS One; 2020; 15(9):e0238686. PubMed ID: 32881977
[TBL] [Abstract][Full Text] [Related]
27. Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B:
Astermark J; Hermans C; Ezzalfani M; Sidhom A; Barbier S; Kragh N; Falk A; Eriksson D
Ther Adv Hematol; 2023; 14():20406207231170701. PubMed ID: 37283819
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia B.
Windyga J; Lissitchkov T; Stasyshyn O; Mamonov V; Rusen L; Lamas JL; Oh MS; Chapman M; Fritsch S; Pavlova BG; Wong WY; Abbuehl BE
Haemophilia; 2014 Jan; 20(1):15-24. PubMed ID: 23834666
[TBL] [Abstract][Full Text] [Related]
29. Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis.
Hermans C; Marino R; Lambert C; Mangles S; Sommerer P; Rives V; Maro G; Malcangi G
Adv Ther; 2020 Jun; 37(6):2988-2998. PubMed ID: 32333327
[TBL] [Abstract][Full Text] [Related]
30. Interpreting important health-related quality of life change using the Haem-A-QoL.
Wyrwich KW; Krishnan S; Poon JL; Auguste P; von Maltzahn R; Yu R; von Mackensen S
Haemophilia; 2015 Sep; 21(5):578-84. PubMed ID: 25828456
[TBL] [Abstract][Full Text] [Related]
31. Health-related quality of life in paediatric haemophilia B patients treated with rIX-FP.
von Mackensen S; Shah J; Seifert W; Kenet G
Haemophilia; 2019 Jan; 25(1):45-53. PubMed ID: 30427091
[TBL] [Abstract][Full Text] [Related]
32. The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.
O'Hara J; Walsh S; Camp C; Mazza G; Carroll L; Hoxer C; Wilkinson L
Health Qual Life Outcomes; 2018 May; 16(1):84. PubMed ID: 29720192
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).
Mahlangu J; Oldenburg J; Callaghan MU; Shima M; Mancuso ME; Trask P; Recht M; Garcia C; Yang R; Lehle M; Macharia H; Asikanius E; Levy GG; Kruse-Jarres R; von Mackensen S
Haemophilia; 2019 May; 25(3):382-391. PubMed ID: 31016855
[TBL] [Abstract][Full Text] [Related]
34. Changes in health-related quality of life with treatment of longer-acting clotting factors: results in the A-LONG and B-LONG clinical studies.
Wyrwich KW; Krishnan S; Auguste P; Poon JL; von Maltzahn R; Yu R; Pierce GF; Mei B; Mahlangu J; von Mackensen S
Haemophilia; 2016 Nov; 22(6):866-872. PubMed ID: 27385432
[TBL] [Abstract][Full Text] [Related]
35. Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe.
Burke T; Asghar S; O'Hara J; Chuang M; Sawyer EK; Li N
Orphanet J Rare Dis; 2021 Dec; 16(1):521. PubMed ID: 34930388
[TBL] [Abstract][Full Text] [Related]
36. Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO-KLAT.
Tang L; Xu W; Li CG; Hou F; Feng XQ; Wang H; Li XJ; Li WL; Liu JP; Sun LR; Wang SH; Jin J; Fang Q; Luke KH; Poon MC; Blanchette VS; Usuba K; Young NL; Wu R
Haemophilia; 2018 Jan; 24(1):113-119. PubMed ID: 28922525
[TBL] [Abstract][Full Text] [Related]
37. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
George LA; Sullivan SK; Giermasz A; Rasko JEJ; Samelson-Jones BJ; Ducore J; Cuker A; Sullivan LM; Majumdar S; Teitel J; McGuinn CE; Ragni MV; Luk AY; Hui D; Wright JF; Chen Y; Liu Y; Wachtel K; Winters A; Tiefenbacher S; Arruda VR; van der Loo JCM; Zelenaia O; Takefman D; Carr ME; Couto LB; Anguela XM; High KA
N Engl J Med; 2017 Dec; 377(23):2215-2227. PubMed ID: 29211678
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study).
Måseide RJ; Berntorp E; Astermark J; Olsson A; Bruzelius M; Frisk T; Nummi V; Lassila R; Tjønnfjord GE; Holme PA
Haemophilia; 2024 Jan; 30(1):98-105. PubMed ID: 37983883
[TBL] [Abstract][Full Text] [Related]
39. The impact of bleeding event frequency on health-related quality of life and work productivity outcomes in a European cohort of adults with haemophilia A: insights from the CHESS II study.
Young L; Chen Y; Alvir J; Burke T; Ferri Grazzi E; Winburn I
Orphanet J Rare Dis; 2023 Aug; 18(1):227. PubMed ID: 37537683
[TBL] [Abstract][Full Text] [Related]
40. Health-related quality of life and psychological well-being in elderly patients with haemophilia.
von Mackensen S; Gringeri A; Siboni SM; Mannucci PM;
Haemophilia; 2012 May; 18(3):345-52. PubMed ID: 21910788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
